These findings point toward the idea that myeloid TRPV2‐mediated homeostatic Ca2+ facilitates the entry and infection of viruses and that selectively targeting the Ca2+ permeability of TRPV2 might represent potential therapeutic strategies for treatment of viruses‐caused diseases. The gene discussed is TRPV2; the disease is infection.